CompletedNCT00266552
Official study titleThe Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder and Other Disruptive Behavior Disorders In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 5–12
- Countries
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
CompletedNCT01199315
Official study titleA Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 in Young and Elderly Healthy Japanese Volunteers After Oral Single and Repeated Doses
This study has finished and is no longer accepting participants.
In FukuokaADHDMedication studyAges 20–80
- Countries
- Japan
- Sponsor
- AstraZeneca
CompletedNCT02144415
Official study titleA Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
This study has finished and is no longer accepting participants.
In Overland ParkADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT06966973
Official study titlePediatric Polysomnography at Home: Feasibility, Quality, and Satisfaction in Normal Children and Children With Neurodevelopmental Disorders
This study has finished and is no longer accepting participants.
In GarchesADHDObservational studyAges 2–17
- Countries
- France
- Sponsor
- UPNOS
CompletedNCT00486551
This study has finished and is no longer accepting participants.
In New HavenADHDBehavioural studyAges 11–16
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT04481048
Official study titleAntioxidant Therapy With N-acetylcysteine for Motor Behavior and/or Learning in Children With Neurofibromatosis Type 1
This study has finished and is no longer accepting participants.
In CincinnatiADHDMedication studyAges 8–16
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT02423746
This study has finished and is no longer accepting participants.
Multiple locations, including LexingtonADHDBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of Kentucky
CompletedNCT00368849
Official study titleAtomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study
This study has finished and is no longer accepting participants.
In Iowa CityADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Iowa
CompletedNCT01263756
Official study titleA Study of the Driving Performance of Individuals With Autism Spectrum Disorders
This study has finished and is no longer accepting participants.
In CambridgeADHDObservational studyAges 16–50
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00060723
Official study titleBehavioral Effect of Obstructive Sleep Apnea in Children
This study has finished and is no longer accepting participants.
In Ann ArborADHDObservational studyAges 5–12
- Countries
- United States
- Sponsor
- University of Michigan
CompletedNCT02694003
Official study titleDevelopment, Implementation, and Evaluation of an Internet-based Behavioural Sleep Intervention for Children With NDD and Insomnia
This study has finished and is no longer accepting participants.
In HalifaxADHDBehavioural studyAges 4–12
- Countries
- Canada
- Sponsor
- IWK Health Centre
CompletedNCT03490110
Official study titleEEG Markers of Training-Induced Improvements in Cognitive Functioning
This study has finished and is no longer accepting participants.
In SacramentoADHDBehavioural studyAges 21–55
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)